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Abstract
Background & Aims: Non-alcoholic steatohepatitis (NASH) is characterized by steatosis and inflammation, which can further
progress into fibrosis and cirrhosis. Recently, we demonstrated that combined deletion of the two main scavenger
receptors, CD36 and macrophage scavenger receptor 1 (MSR1), which are important for modified cholesterol-rich
lipoprotein uptake, reduced NASH. The individual contributions of these receptors to NASH and the intracellular
mechanisms by which they contribute to inflammation have not been established. We hypothesize that CD36 and MSR1
contribute independently to the onset of inflammation in NASH, by affecting intracellular cholesterol distribution inside
Kupffer cells (KCs).
Methods & Results: Ldlr
2/2 mice were transplanted with wild-type (Wt), Cd36
2/2 or Msr1
2/2 bone marrow and fed a
Western diet for 3months. Cd36
2/2- and Msr1
2/2- transplanted (tp) mice showed a similar reduction in hepatic
inflammation compared to Wt-tp mice. While the total amount of cholesterol inside KCs was similar in all groups, KCs of
Cd36
2/2- and Msr1
2/2-tp mice showed increased cytoplasmic cholesterol accumulation, while Wt-tp mice showed
increased lysosomal cholesterol accumulation.
Conclusion: CD36 and MSR1 contribute similarly and independently to the progression of inflammation in NASH. One
possible explanation for the inflammatory response related to expression of these receptors could be abnormal cholesterol
trafficking in KCs. These data provide a new basis for prevention and treatment of NASH.
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Introduction
Non-alcoholic steatohepatitis (NASH) is increasingly recognized
as a major health burden in developed countries, with a
prevalence of 2–3% in the general population and up to 37% of
the severely obese population of Western countries [1]. It is
characterized by hepatic lipid accumulation (steatosis) combined
with inflammation. While steatosis itself is generally considered
benign, the presence of inflammation can lead to progression of
NASH, resulting in liver fibrosis, cirrhosis and eventually liver
failure and hepatocellular carcinoma [2]. The inflammatory
response in the liver represents a key step in NASH development
as it contributes to further liver damage by cirrhosis and
hepatocellular carcinoma.
We have previously shown that hyperlipidemic mice fed a
Western diet show an early onset of hepatic inflammation, which is
associated with bloated Kupffer cells (KCs). These KCs resemble
the foam cells of atherosclerotic lesions [3]. The current view
favours a model where scavenger receptors (SR) mediate uptake of
oxidized lipoproteins by macrophages, leading to foam cell
formation and initiation of the inflammatory response. In line
with this, we have already shown that the haematopoietic deletion
of scavenger receptors Cd36 and macrophage scavenger receptor 1
(Msr1) in low density lipoprotein (LDL) receptor-deficient (Ldlr
2/2)
mice attenuates hepatic inflammation [4]. However, while hepatic
inflammation, lipid oxidation and liver fibrosis were significantly
reduced, these mice showed no difference in foamy KCs.
Similarly, it has also been shown that deletion of CD36, MSR1
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in vivo. In terms of atherosclerosis, there is controversy as to
whether there are reduced lesions in apoE/Cd36/Msr1 triple
knock-out mice, but there is consensus that absence of these
receptors reduced lesion complexity and inflammation [5,6].
Thus, in contrast to the current view, these observations suggest
that scavenger receptors modulate inflammation without altering
total lipid accumulation in macrophages. Likewise, there is a
growing appreciation of the numerous similar but independent
functions of each one of these scavenger receptors in addition to
lipoprotein uptake, including their role in inflammatory signal
transduction and tissue homeostasis [7]. Currently, the individual
contributions of these receptors to the onset of inflammation and
the intracellular mechanisms by which they contribute to
inflammation have not yet been established. Based on their
different functions in inflammatory signal transduction, we
hypothesized that CD36 and MSR1 contribute independently to
the onset of hepatic inflammation, by affecting intracellular
cholesterol distribution inside KCs.
Under normal conditions, lipoproteins which are endocytosed
by KCs will initially be directed to the lysosomes, where they are
hydrolyzed by lysosomal enzymes and transferred into the
cytoplasm. However, the uptake of oxLDL by macrophages,
which is modulated by CD36 and MSR1, is associated with
lysosomal trapping in vitro [8]. Several lines of evidence indicate an
association between lysosomal cholesterol accumulation and
inflammation [9–12].
In order to investigate whether a macrophage-specific deletion
of each scavenger receptor individually affects hepatic inflamma-
tion, Ldlr
2/2 mice were lethally irradiated and transplanted with
bone marrow from Wild type (Wt), Msr1
2/2 or Cd36
2/2 mice and
fed a high-fat-high-cholesterol (HFC) diet for 3 months. We found
that CD36 and MSR1 contribute in a similar manner to the
progression of NASH in the presence of high levels of plasma-
modified lipoproteins. The effect of these receptors on inflamma-
tion is likely modulated via impaired cholesterol trafficking inside
KCs and increased lysosomal cholesterol accumulation.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Committee for Animal Welfare of
Maastricht University (Permit Number: 2006-177). The investi-
gation conforms to the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health (NIH
Publication No. 85–23, revised 1996).
Mice and diet
Mice were housed under standard conditions and given free
access to food and water. Female Ldlr
2/2 mice were lethally
irradiated and transplanted with Wt, Cd36
2/2 and Msr
2/2 bone
marrow as previously described [4]. After a recovery period of 9
weeks, the mice were given a HFC diet for 3 months (n=9 Wt-tp
mice, n=8 for both Cd36
2/2-tp and Msr1
2/2-tp mice),
containing 21% milk butter, 0.2% cholesterol, 46% carbohydrates
and 17% casein. Collection of blood and specimens, biochemical
determination of lipids in plasma and liver, liver histology, RNA
isolation, cDNA synthesis and qPCR, aminotransferases, oxyster-
ols and auto-antibody titers against IgG and IgM antibodies to
CuOx-LDL and MDA-LDL, as well as T15id+ IgM were
determined as previously described [4].
Electron microscopy
A detailed overview about the (post)fixation, embedding, cutting
and type of electron microscope was described previously [3].
Scoring of electron microscopy (EM) pictures was performed by a
trained specialist. Fifty KCs per mouse were analysed and scored.
The KCs were divided into three different categories, i.e., primary
lysosomes, secondary fatty lysosomes and cytoplasmic fat accu-
mulation and the percentage of each subtype was calculated.
Furthermore, the secondary fatty lysosomes were scored from 0 to
3 for their fat content, where a score of 0 indicated not positive and
a score of 3 indicated extreme fat accumulation inside the
lysosomes of the KCs. The same scoring index was used for the
cytoplasmic fat accumulation inside KCs.
Statistical analysis
The data were statistically analysed by performing a one-way
ANOVA test with a Bonferroni post-test using GraphPad Prism
for comparing Wt-tp, Cd36
2/2-tp and Msr
2/2-tp mice with each
other. The same was done for the human samples where the
different groups of patients were compared with each other. The
data were expressed as mean 6 SEM and considered significant at
p,0.05. *, ** and *** indicate p,0.05, 0.01 and 0.001,
respectively.
Results
Inflammation is reduced in Cd36
2/2-tp and Msr1
2/2-tp
mice compared to Wt-tp mice
To determine whether both Cd36 and Msr1 are independently
involved in diet-induced hepatic inflammation, Ldlr
2/2 mice were
transplanted with Cd36
2/2 or Msr1
2/2 bone marrow and fed a
HFC diet for 3 months. Immunohistochemistry revealed that
infiltrated macrophages and neutrophils were significantly de-
creased in the livers of mice transplanted with both Cd36
2/2 and
Msr1
2/2 bone marrow compared to Wt- transplanted (tp) mice
(Fig. 1A+B+D). The same decrease was seen after staining with an
antibody against myeloperoxidase (MPO), which is an oxidative
stress/neutrophil marker (Fig. 1C). These data on inflammation
were confirmed by a general HE staining, indicating less hepatic
inflammation in Cd36
2/2- and Msr1
2/2-tp mice (Fig. 2).
The plasma transaminases alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) are considered as sensitive
indicators of liver damage. Although the ALT levels were equal
in all transplanted groups, the AST levels were significantly lower
in Cd36
2/2-tp and Msr1
2/2-tp mice compared to Wt-tp mice.
Moreover, the ratio of AST/ALT was lower in Msr1
2/2-tp mice
compared to Wt-tp mice (Table 1). In general, these data indicate
that both Cd36
2/2-tp and Msr1
2/2-tp mice showed less liver
damage.
The reduced inflammatory response in Cd36
2/2-tp and
Msr1
2/2-tp mice is not correlated with the changes in
lipid levels
To determine whether deletion of Cd36 and Msr1 on bone
marrow cells affected steatosis, liver lipid levels were analysed in
order to investigate the extent of steatosis present in these mice.
Table 1 show that liver triglycerides (TG), free fatty acids (FFA)
and total cholesterol were all higher in the Msr1
2/2-tp mice
compared to Wt-tp mice. The amount of cholesterol esters (CE) in
the liver was elevated in both Cd36
2/2-tp and Msr1
2/2-tp mice
compared to Wt-tp mice. Desmosterol, a cholesterol synthesis
marker, was decreased in the Msr1
2/2-tp mice compared to Wt-tp
mice, whereas the cholesterol absorption marker cholestanol was
Individual Contribution of CD36 and SR-A in NASH
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2/2-tp mice compared to Wt-tp and Cd36
2/2-tp
mice (Table 1). Nevertheless, HE staining (Fig. 2) and Oil red O
staining (data not shown) revealed no differences between any of
the groups. Thus, the observed differences found in hepatic
steatosis between Wt-tp, Cd36
2/2-tp and Msr1
2/2-tp mice were
mild and not consistent.
Table 1 shows that plasma TG and total cholesterol were
similar in all transplanted groups. Plasma FFA levels were
significantly lower in Msr1
2/2-tp mice compared to Wt-tp mice.
Although the total amount of cholesterol did not differ between the
groups, the cholesterol synthesis markers lathosterol and desmos-
terol were significantly lower in the plasma of Msr1
2/2-tp mice
compared to Wt-tp mice. Moreover, the cholesterol absorption
marker cholestanol was significantly higher in both Cd36
2/2-tp
and Msr1
2/2-tp mice compared to Wt-tp mice. Plasma levels of
7a-hydroxy (OH) cholesterol were decreased in both Cd36
2/2-tp
and Msr1
2/2-tp mice compared to Wt-tp mice, while the other
oxysterols (24-OH and 27-OH cholesterol) were not different from
Wt-tp mice. Overall, these plasma lipid data were inconclusive and
did not reveal any major differences between Wt-tp, Cd36
2/2-tp
and Msr1
2/2-tp mice.
In order to investigate whether natural antibodies, known to
decrease atherogenesis, are affected by deletion of Cd36 and Msr1,
the protective immunoglobulin M auto-antibody levels against
MDA-LDL, Cu-OxLDL and T15id+ were measured and showed
significantly higher levels in Msr1
2/2-tp mice compared to Wt-tp
mice and Cd36
2/2-tp mice. The Cu-OxLDL and T15id+ IgM
auto-antibodies were also elevated in Cd36
2/2-tp mice compared
Figure 1. Parameters of hepatic inflammation. (A–C) Liver sections were stained for infiltrated macrophages and neutrophils (Mac-1),
neutrophils (NIMP) and MPO (D) Representative pictures of Mac-1 staining (6200 magnification) after 3 months of HFC feeding in Wt-tp, Cd36
2/2-tp
and Msr1
2/2-tp mice. *Significantly different from Wt-tp group. * and ** indicate p,0.05 and 0.01, respectively.
doi:10.1371/journal.pone.0034378.g001
Figure 2. General histology of the liver. HE staining on livers of Wt-tp (A), Cd36
2/2-tp (B) and Msr1
2/2-tp (C) mice indicating steatosis and
inflammation (arrows).
doi:10.1371/journal.pone.0034378.g002
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2/2-tp and Msr1
2/2-tp mice have
an increased protective phenotype compared to Wt-tp mice.
No difference in the foamy appearance of Kupffer cells
To characterize the KCs, immunohistochemistry for CD68
(macrophage marker) was performed. This staining revealed no
differences in the size or presence of KCs between Wt-tp,
Cd36
2/2-tp and Msr1
2/2-tp mice (Fig. 3A–C). Moreover,
CD68 mRNA expression showed similar results (data not
shown).
Cd36
2/2-tp and Msr1
2/2-tp mice have decreased
lysosomal cholesterol storage inside the KCs compared
to Wt-tp mice
To determine whether the reduced inflammatory response in
Cd36
2/2-tp and Msr1
2/2-tp mice was associated with decreased
lysosomal fat accumulation, detailed analyses of the KCs were
performed using electron microscopy (EM) (Fig. 4A–C). Interest-
ingly, lipid distribution inside these cells revealed a clear difference
between Wt-tp and Cd36
2/2 -tp/Msr1
2/2 -tp mice (Fig. 4D).
Cd36
2/2-tp and Msr1
2/2-tp mice showed decreased lysosomal
Table 1. Parameters for lipid related products in liver and plasma.
Wt-tp mice Cd36
2/2-tp mice Msr1
2/2-tp mice
Liver
Triglycerides (mg) 0.38 (60.02) 0.40 (60.03) 0.47 (60.02)*
Free fatty acids (mg) 0.17 (60.003) 0.19 (60.006) 0.20 (60.01)*
Cholesterol (mg) 0.08 (60.0038) 0.10 (60.0062) 0.11 (60.0071)**
Lathosterol (ng/mg liver) 21.8 (61.76) 19.71 (62.44) 19.10 (62.55)
Desmosterol (ng/mg liver) 16.11 (61.06) 14.44 (60.85) 12.62 (60.92)*
Cholestanol (ng/mg liver) 93.03 (68.42) 97.33 (66.38) 126.7 (611.22)*, #
Cholesterol esters (mg/mg liver) 14.37 (61.58) 21.2 (61.88)* 20.99 (61.27)**
Free cholesterol (mg/mg liver) 8.63 (60.28) 9.00 (60.23) 8.16 (60.36)
Plasma
Triglycerides (mM) 1.49 (60.16) 1.29 (60.14) 1.27 (60.18)
Free fatty acids (mM) 0.58 (60.04) 0.59 (60.06) 0.45 (60.03)
Cholesterol (mg/dl) 1052 (6113.1) 1210 (637.76) 1097 (669.45)
Lathosterol (mg/dl) 0.31 (60.03) 0.24 (60.04) 0.17 (60.03)**
Desmosterol (mg/dl) 0.77 (60.06) 0.77 (60.08) 0.52 (60.06)*, #
Cholestanol (mg/dl) 3.03 (60.31) 4.34 (60.13)** 4.60 (60.14)**
7a-OH cholesterol (ng/ml) 1.50 (60.13) 1.02 (60.13)* 0.92 (60.03)**
24-OH cholesterol (ng/ml) 448.8 (646.85) 506.5 (628.77) 505.6 (641.62)
27-OH cholesterol (ng/ml) 504 (659.81) 504.8 (642.63) 455 (646.12)
MDA-LDL IgM (RLU) 86348 (64857) 89405 (66189) 113896 (62889)***,##
CuOx-LDL IgM (RLU) 31987 (66331) 62903 (611844)* 102371 (66341)***,##
T15id+ (IgM) (RLU) 3726 (6395.2) 9000 (61815)* 19079 (63412)**, #
ALT (U/l) 61 (69.35) 58.43 (63.40) 65.5 (63.53)
AST (U/l) 129.5 (613.77) 79 (614.3)* 84 (66.52)*
AST/ALT 2.25 (60.38) 1.52 (60.15) 1.28 (60.07)*
*Significantly different from Wt-tp group. *, ** and *** indicate p,0.05, 0.01 and 0.001, respectively. RLU: Relative light unit.
#Significantly difference between Cd36
2/2-tp and Msr1
2/2-tp mice. # and ## indicate p,0.05 and 0.01 respectively.
doi:10.1371/journal.pone.0034378.t001
Figure 3. Foamy Kupffer cells. CD68 staining of Kupffer cells in liver of Wt-tp (A), Cd36
2/2-tp (B) and Msr1
2/2-tp (C) mice.
doi:10.1371/journal.pone.0034378.g003
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whereas the first two had increased cytoplasmic fat storage
compared to Wt-tp mice (Fig. 4E+F). Moreover, Wt-tp mice had
more primary and secondary lysosomes compared to Cd36
2/2-tp
and Msr1
2/2-tp mice.
Discussion
Our study showed for the first time that the uptake of modified
lipids in vivo leads to lysosomal cholesterol accumulation in KCs.
By specifically inactivating one of the two predominant scavenger
receptors on macrophages, we established that the contribution of
each one of these two receptors to hepatic inflammation is similar.
Internalization of lipids by these receptors leads to increased levels
of cholesterol in lysosomes and increased hepatic inflammation.
CD36 and MSR1 contribute in a similar manner to the
progression of NASH
Currently, the risk factors that drive hepatic inflammation
during the progression of NASH are largely unknown. We
previously showed that hyperlipidemic mice are more sensitive to
developing early diet-induced NASH [3]. We also demonstrated
that the increased sensitivity of these mice towards developing
NASH is related to the expression of Msr1 and Cd36 [4].
Scavenger receptors MSR1 and CD36 have been identified as
the principal receptors responsible for the uptake of modified lipids
and cholesterol into macrophages [13]. MSR1 was found to
account for the majority (80%) of the macrophage uptake of
acetylated low density lipoproteins (acLDL), but it also binds
oxidized LDL (oxLDL), albeit with lower affinity. CD36 binds
oxLDL rather than acLDL, and it is involved in oxLDL-induced
JNK activation. While the relative affinities of MSR1 and CD36 to
modified and oxidized lipids are different, the effects on
inflammation in our study were similar. These results are
surprising, since it was found that cultured macrophages incubated
with oxLDL showed lysosomal cholesterol accumulation while
incubation with acLDL did not lead to lysosomal cholesterol
accumulation but rather to cytoplasmic cholesterol storage inside
macrophages [8]. Thus, it is possible that in contrast to the in vitro
data, the affinity of both receptors towards oxLDL in vivo is similar.
Another possible explanation is that the markedly increased levels
of oxLDL in the plasma of Ldlr
2/2 mice fed the HFC diet
exceeded the maximal amount of cholesterol that can be taken up
by KCs and trapped inside their lysosomes. The scavenger
receptors CD36 and MSR1 differ from each other not only in
their relative affinities to modified and oxidized lipids, but also in
their signalling pathways and other important functions triggered
by the binding and uptake of modified LDL, such as innate
immune responses, cellular adhesion, and the phagocytosis of
apoptotic cells [7]. These functions may also be involved in the
development of NASH. The similarity in the degree of
inflammation between the two models suggests that this inflam-
mation is a consequence of the two receptors sharing similar
modified lipid internalization mechanisms, rather than each
receptor having its own specialized functions. In line with this
hypothesis, previous studies with MSR1 and CD36-knockout mice
showed that disruption of each receptor pathway partially
inhibited the uptake of modified LDL in macrophages and
retarded atherosclerosis progression in a similar manner [14–16].
All together, this study provides evidence of a central contribution
of both of these receptors to the pathogenesis of NASH. Further
investigations are necessary to determine the exact interaction
between CD36 and MSR1 upon the internalization of lipids.
Hepatic inflammation is correlated with increased
lysosomal cholesterol accumulation
Interestingly, it was shown that lysosomal cholesterol accumu-
lation in vitro was associated with increased pH inside lysosomes
[17], which can lead to partial lysosomal enzyme inactivation and
an inflammatory response. Similarly, it was shown that in foam
cells of advanced atherosclerotic plaques, cholesterol is not
transferred into the cytoplasm but rather accumulates in the
lysosomes of the macrophages [18]. Several lines of evidence
further indicate an association between lysosomal cholesterol
accumulation and inflammation: first, lysosomal acid lipase (LAL)
is the essential enzyme for the hydrolysis of triglycerides and
cholesteryl esters in lysosomes. Similar to our observations in
hyperlipidemic mice, a deficiency of this enzyme was found to lead
to lysosomal cholesterol accumulation and inflammation [12].
Moreover, exogenous LAL administration in Ldlr
2/2 mice led to a
significant reduction in hepatic inflammation and lipid accumu-
lation. Furthermore, the macrophage-specific expression of human
LAL was found to correct inflammation in Lal
2/2 mice [12].
Likewise, patients with mutations in Niemann-Pick type C (NPC) 1
and 2, proteins which facilitate the movement of cholesterol from
the lysosomes to the cytoplasmic compartment, commonly have a
very poorly functioning liver, and about 10% of these patients dies
from liver failure [19,20]. Second, lysosomes have been assigned a
central role in many processes involving tissue injury and
inflammation [21]. Likewise, increased lysosomal cholesterol
accumulation contributes to disturbed autophagy, a process that
has recently emerged as an important regulatory pathway of the
innate immune response [22]. Finally, it was recently demonstrat-
ed that oxLDL has the potential to damage lysosomal membranes
and thereby prime cells for inflammation [23].
Taken altogether, our novel observations point towards the role
of scavenger receptors during hepatic inflammation, resulting in
abnormal cholesterol trafficking in KCs. These data provide a new
basis for prevention and treatment of NASH.
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Figure 4. Electron microscopic views of Kupffer cells (K) after 3 months of a high fat diet. (A) The Kupffer cell of Wt-tp mice shows several
fatty lysosomes (*). Primary lysosomes (#) and secondary lysosomes without fat accumulation (+) can be seen as well. Kupffer cells of Cd36
2/2 -tp (B)
and Msr1
2/2 -tp (C) mice show massive cytoplasmic lipid accumulation (=). H: hepatocytes. (D) Percentage of Kupffer cells with primary lysosomes,
secondary fatty lysosomes and cytoplasmic fat accumulation. (E+F) Arbitrary scoring of secondary fatty lysosomes and cytoplasmic fat accumulation
inside Kupffer cells. *Significantly different from Wt-tp group. * and ** indicate p,0.05 and 0.01, respectively.
doi:10.1371/journal.pone.0034378.g004
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